IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: billkirn who wrote (541)	4/4/1997 12:10:00 AM
From: I. Luttichuys	of 1762

Well I know what Roader gettin' at. When things get nasty or slow with IDEC I start talking about something else :o(. You aren't alone with that buy... I picked some up as well and bought some GCR. I don't think we've seen the bottom yet on IDEC for some reason. Seems like the downwards momentum is still pretty good but, I did it anyway as we can always be patient and you know how this one can turn around. SmithKline certainly has sold the lion's share in the past. I am curious as to why they would be doing this with such abandon. Is this a common occurance among biotechs which have investments in each other? I am not worried about it or I wouldn't be buying, obviously, and because there has been a great deal of knowledge shared here on the company and I am very comfortable with all that I have personally heard from and about this company but, I'd just like to know so I can interpret these events in the future. Right now I look at it the same way I look at insider sales although these are not insider sales... that is: I feel they are obviously not the same thing but I interpret their meaning as being similar in that it is not good news but, it is not necessarily bad news. There are many reasons why an insider might sell a stock which are quite independent of whether or not that insider feels the stock will move up in the near term. The insider may simply need the money and need it soon for something as harmless as his daugher's college tuition. Buying is a different matter though. I figure an insider usually only buys because he likes the stock. That's a similarity I see with this activity. Not good news but, not necessarily bad. So... SmithKline's activity... not worried about but would like the reason identified anyway. Maybe I'll learn something about biotechs. BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next